Anatomical Study of the Arteries of the Skin on Amputation Legs

NCT ID: NCT03618615

Last Updated: 2018-09-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-09-30

Study Completion Date

2021-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

PRIMARY OBJECTIVE Qualitatively describe the distribution of cutaneous arteries in patients with long-term occlusive arterial disease.

SECONDARY OBJECTIVE To compare the distribution of cutaneous arteries observed on the legs of arteritic patients with that observed on non-arteritic legs (from bodies given to science).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Arterial patient coming to CHRU Nancy, in the Vascular and Endoluminal Surgery Department, to undergo leg amputation.

Usually, after the amputation of the leg in the operating theatre, the surgical waste is destroyed.

Instead of being destroyed, the leg will be used for research.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arteritic Leg Ulcer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

artericitc surgery

biological sample (leg) from leg amputation surgery used for research

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Major Patient
* Patient with late stage occlusive arteriopathy with lower limb amputation
* Patient who did not oppose the search
* Patient affiliated to a social security scheme

Exclusion Criteria

* Patients with infectious diseases not accessible in the anatomy laboratory
* Woman of childbearing age without effective contraception
* Persons referred to in Articles L. 1121-5 to L. 1121-8 and L1122-2 of the Public Health Code :
* Pregnant woman, parturient or nursing mother
* Person deprived of liberty by a judicial or administrative decision,
* Person under psychiatric care pursuant to Articles L.3212-1 and L.3213-1 of the Public Health Code
* Person admitted to a health or social institution for purposes other than research
* Minor person (not emancipated)
* Adult subject to a legal protection measure (guardianship, trusteeship, protection of justice)
* Major person who is not in a position to express consent and who is not subject to a legal protection measure
Minimum Eligible Age

18 Years

Maximum Eligible Age

95 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Central Hospital, Nancy, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2017-A02936-47

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.